Does TOFACITINIB Cause Respiratory tract infection? 435 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 435 reports of Respiratory tract infection have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
435
Reports of Respiratory tract infection with TOFACITINIB
0.3%
of all TOFACITINIB reports
32
Deaths
100
Hospitalizations
How Dangerous Is Respiratory tract infection From TOFACITINIB?
Of the 435 reports, 32 (7.4%) resulted in death, 100 (23.0%) required hospitalization, and 32 (7.4%) were considered life-threatening.
Is Respiratory tract infection Listed in the Official Label?
Yes, Respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Respiratory tract infection?
RITUXIMAB (1,058)
PREDNISONE (1,051)
OMALIZUMAB (927)
ADALIMUMAB (913)
METHOTREXATE (895)
ETANERCEPT (848)
HUMAN IMMUNOGLOBULIN G (764)
LENALIDOMIDE (731)
DEXAMETHASONE (684)
ALBUTEROL (601)
Which TOFACITINIB Alternatives Have Lower Respiratory tract infection Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN